Stock Events

Stock Events

Xilio Therapeutics (XLO) Q3 2025 Earnings

14AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.25

-0.19

-0.13

-0.08

Details

Expected EPS

-0.0788

Actual EPS

-0.16

Surprise EPS

-0.08

Surprise Percent

+103.05%

Description

Xilio Therapeutics (XLO) has reported earnings of -0.16 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.